Potentiation of the "dopa" effect in parkinsonism by a direct GABA receptor agonist.
D000927:Anticonvulsants / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004357:Drug Synergism; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage*; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology; D011956:Receptors, Cell Surface / Q000187:drug effects*; D011963:Receptors, GABA-A; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage / Q000031:analogs & derivatives*
D000927:Anticonvulsants; D011956:Receptors, Cell Surface; D011963:Receptors, GABA-A; C017985:progabide; D007980:Levodopa; D005680:gamma-Aminobutyric Acid